News

  • The OME Team has been awarded a £1.4M Biomedical Resource Award from the Wellcome Trust to extend the capabilities of its Bio-Formats image file reading library.

  • First training in the Cryo EM facility took place on Friday 26th August. It is hoped that the facility will provide a valuable new approach for researchers studying protein structure.

  • Embryonic stem cells have the unique ability to differentiate into the many different cell lineages found in the body.  These changes in cell identity are driven by the co-ordinated regulation of large cohorts of genes.  Laura Grasso and Olga Suska, PhD students at the Centre for Gene Regulation

  • In mammals, the mRNA cap structure is critical for genes to be read and proteins to be produced.

  • The OME Consortium, led by Jason Swedlow’s Dundee-based OME Team, holds its 11th Annual Meeting this week, Tuesday 31st May – Thursday 2nd June at the Dalhousie Building and the Discovery Centre.
     
  • In an international collaboration with researchers and clinicians from Germany and Iran, GRE scientists Iain Porter and Jason Swedlow have demonstrated that a protein called Bod1, which they initially discovered based on its important role in regulating how cancer cells divide, is also critical

  • Dr Ross Fennessy and Prof Tom Owen-Hughes have published a study showing that the positions which nucleosomes occupy are restored within a few minutes of DNA replication.

  • Professor Martin Chalfie of Columbia University obtained his B.A. and PhD from Harvard University and did post-doctoral research with Sydney Brenner at the MRC Laboratory of Molecular Biology, Cambridge, before moving to Columbia in 1982.

  • Dr Michael Aregger, Dr Victoria Cowling and colleagues have published a study which reveals how transcription and mRNA capping are co-ordinated during the burst of gene expression that occurs after new cells are formed.  mRNA typically comprises less than 5% of cellular RNA; mRNA capping flags t

  • Vast amounts of data generated by screening patients for diseases like cancer and arthritis at The University of Manchester will now be used to improve treatment and drug safety in partnership with the University of Dundee.
     

Pages